MedPath
PPB Approval

RINVOQ PROLONGED-RELEASE TABLETS 15MG

HK-66872

Prescription only Medicines

October 30, 2020

AbbVie Limited

Company Information

Company Details

AbbVie Limited

UNIT 2405-08 24/F, AIA TOWER, 183 ELECTRIC ROAD, NORTH POINT, HONG KONG

Active Ingredients

upadacitinib

Drug Monographs

Upadacitinib

乌帕替尼

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RINVOQ PROLONGED-RELEASE TABLETS 15MG - PPB 批准文号 | MedPath